A novel HSPB1S139F mouse model of Charcot-Marie-Tooth Disease
Document Type
Article
Publication Date
8-23-2023
Original Citation
Espinoza K,
Hermanson K,
Beard C,
Schwartz N,
Snider J,
Low BE,
Wiles MV,
Hannun Y,
Obeid L,
Snider A.
A novel HSPB1S139F mouse model of Charcot-Marie-Tooth Disease Prostaglandins Other Lipid Mediat. 2023;169:106769.
Keywords
JMG
JAX Source
Prostaglandins Other Lipid Mediat. 2023;169:106769.
ISSN
1098-8823
PMID
37625781
DOI
https://doi.org/10.1016/j.prostaglandins.2023.106769
Grant
This work was supported by the National Institute for Neurologic Disorders and Stroke at the National Institutes of Health R03 NS111420 (AJS).
Abstract
Charcot-Marie-Tooth Disease (CMT) is a commonly inherited peripheral polyneuropathy. Clinical manifestations for this disease include symmetrical distal polyneuropathy, altered deep tendon reflexes, distal sensory loss, foot deformities, and gait abnormalities. Genetic mutations in heat shock proteins have been linked to CMT2. Spe- cifically, mutations in the heat shock protein B1 (HSPB1) gene encoding for heat shock protein 27 (Hsp27) have been linked to CMT2F and distal hereditary motor and sensory neuropathy type 2B (dHMSN2B) subtype. The goal of the study was to examine the role of an endogenous mutation in HSPB1 in vivo and to define the effects of this mutation on motor function and pathology in a novel animal model. As sphingolipids have been implicated in hereditary and sensory neuropathies, we examined sphingolipid metabolism in central and peripheral nervous tissues in 3-month-old HspS139F mice. Though sphingolipid levels were not altered in sciatic nerves from HspS139F mice, ceramides and deoxyceramides, as well as sphingomyelins (SMs) were elevated in brain tissues from HspS139F mice. Histology was utilized to further characterize HspS139F mice. HspS139F mice exhibited no alter- ations to the expression and phosphorylation of neurofilaments, or in the expression of acetylated α-tubulin in the brain or sciatic nerve. Interestingly, HspS139F mice demonstrated cerebellar demyelination. Locomotor function, grip strength and gait were examined to define the role of HspS139F in the clinical phenotypes associated with CMT2F. Gait analysis revealed no differences between HspWT and HspS139F mice. However, both coordi- nation and grip strength were decreased in 3-month-old HspS139F mice. Together these data suggest that the endogenous S139F mutation in HSPB1 may serve as a mouse model for hereditary and sensory neuropathies such as CMT2F.